StonvexLoading…
StonvexStonvexStonvexCore line items from TT's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $4.97B | $21.32B | $16.18B | $10.43B |
Operating Income | $776.10M | $3.97B | $3.15B | $1.98B |
Net Income | $584.40M | $2.92B | $2.33B | $1.48B |
EPS (Diluted) | $2.62 | $12.98 | $10.33 | $6.55 |
Total Assets | $22.75B | $21.42B | $21.37B | $20.99B |
Total Liabilities | $14.14B | $12.82B | $13.03B | $13.14B |
Cash & Equivalents | Not available | $1.76B | Not available | Not available |
Free Cash Flow OCF − CapEx | $546.50M | $2.81B | $1.76B | $822.80M |
Shares Outstanding | 223.10M | 224.90M | 225.30M | 225.80M |